![Daniel Chai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Daniel Joon-Byung Chai is the founder of Turret Capital Management, LP, founded in 2016, where the title held is Managing Partner.
Dr. Chai is also the founder of Sable Therapeutics,Milu Labs Ltd.,Egret Therapeutics, Inc...
Dr. Chai was Managing Director at Tucker Anthony Sutro from 1998 to 1999.
Dr. Chai was Managing Director at Neuberger Berman BD LLC (Investment Management) from 2000 to 2003.
Dr. Chai was Senior Analyst at Merlin Biomed Group Hedge Funds from 2004 to 2007.
Dr. Chai was Vice President at Furman Selz LLC from 1996 to 1997.
Dr. Chai was Partner & Head of Risk Management at Iguana Healthcare Management LLC from 2012 to 2015.
Dr. Chai was Portfolio Manager at Citadel Enterprise Americas LLC.
Dr. Chai was Portfolio Manager at UBS Investment Bank (US).
Dr. Chai was Portfolio Manager at Surveyor Capital Ltd. Dr. Chai completed undergraduate studies at the University of Michigan in 1989.
Dr. Chai earned a doctorate from Columbia University Vagelos College of Physicians & Surgeons.
Postes actifs de Daniel Chai
| Sociétés | Poste | Début |
|---|---|---|
Milu Labs Ltd.
 Milu Labs Ltd. Medical/Nursing ServicesHealth Services Operates as a medical diagnostics company | Fondateur | - |
Turret Capital Management, LP
 Turret Capital Management, LP Investment ManagersFinance Turret Capital invests in companies located in the United States. The firm targets companies operating in the field of healthcare technology sector. It participates in early stage capital transactions. | Fondateur | 01/01/2016 |
Egret Therapeutics, Inc.
 Egret Therapeutics, Inc. BiotechnologyHealth Technology Develops immune therapeutics for patients with neurological diseases | Directeur Général | - |
Anciens postes connus de Daniel Chai
| Sociétés | Poste | Fin |
|---|---|---|
Merlin Biomed Group Hedge Funds
 Merlin Biomed Group Hedge Funds Investment ManagersFinance Merlin BioMed invests globally in public and private healthcare companies. The firm's hedge funds and long-term appreciation fund seek maximum capital appreciation from broad-based, global investment in small-, mid- and large-cap public and private companies in the areas of biotechnology, pharmaceuticals, medical devices, healthcare services and research products/services. This investment objective is characterized by an intensive, research-oriented, fundamental, bottom-up approach with a focus on new product innovation as a driver of sales and earnings growth. For private equity, the MerlinNexus objective is to realize long-term capital appreciation from investments in late-stage private companies, PIPEs (private investments in public entities) and select open market transactions. The fund is invested in all segments of the healthcare industry, with an emphasis on product-driven life sciences companies developing breakthrough products that meet clinical needs and can positively alter disease course and associated costs. | Analyst-Equity | 30/11/2007 |
Neuberger Berman BD LLC
 Neuberger Berman BD LLC Investment ManagersFinance NBBD-IM offers clients investment solutions across asset classes, styles, capitalizations and geographies in both public and private markets, as well as multi-asset class solutions that bring them all together. For equity investments, the firm tends to focus on stocks with solid balance sheets, relatively low price-to-earnings ratios, low price-to-cash flow ratios, strong cash flows, above-average yields, sustainable earnings growth, reasonable valuation multiples relative to growth prospects, sound franchise values and significant insider ownership. They use both top-down and bottom-up analysis to select investments. In addition, the firm uses options and futures and occasionally invests in ADRs and private equity opportunities. | Analyst-Equity | 31/12/2003 |
Tucker Anthony Sutro
 Tucker Anthony Sutro Investment Banks/BrokersFinance Provides retail brokerage and investment banking services | Analyst-Equity | 31/12/1999 |
Furman Selz LLC
 Furman Selz LLC Investment Banks/BrokersFinance Provides institutional brokerage and investment banking services | Analyst-Equity | 31/12/1997 |
UBS Investment Bank (US)
 UBS Investment Bank (US) Investment Banks/BrokersFinance Provides investment banking services | Gestionnaire de Portefeuille-Actions | - |
Formation de Daniel Chai
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Tucker Anthony Sutro
Tucker Anthony Sutro Investment Banks/BrokersFinance Provides retail brokerage and investment banking services | Finance |
Merlin Biomed Group Hedge Funds
Merlin Biomed Group Hedge Funds Investment ManagersFinance Merlin BioMed invests globally in public and private healthcare companies. The firm's hedge funds and long-term appreciation fund seek maximum capital appreciation from broad-based, global investment in small-, mid- and large-cap public and private companies in the areas of biotechnology, pharmaceuticals, medical devices, healthcare services and research products/services. This investment objective is characterized by an intensive, research-oriented, fundamental, bottom-up approach with a focus on new product innovation as a driver of sales and earnings growth. For private equity, the MerlinNexus objective is to realize long-term capital appreciation from investments in late-stage private companies, PIPEs (private investments in public entities) and select open market transactions. The fund is invested in all segments of the healthcare industry, with an emphasis on product-driven life sciences companies developing breakthrough products that meet clinical needs and can positively alter disease course and associated costs. | Finance |
Citadel Enterprise Americas LLC
 Citadel Enterprise Americas LLC Investment ManagersFinance Citadel Enterprise invests in public equity, fixed income and alternative investment markets across the globe. The firm seeks to identify the highest and best uses of capital to generate superior long-term returns for their clients. | Finance |
Neuberger Berman BD LLC
Neuberger Berman BD LLC Investment ManagersFinance NBBD-IM offers clients investment solutions across asset classes, styles, capitalizations and geographies in both public and private markets, as well as multi-asset class solutions that bring them all together. For equity investments, the firm tends to focus on stocks with solid balance sheets, relatively low price-to-earnings ratios, low price-to-cash flow ratios, strong cash flows, above-average yields, sustainable earnings growth, reasonable valuation multiples relative to growth prospects, sound franchise values and significant insider ownership. They use both top-down and bottom-up analysis to select investments. In addition, the firm uses options and futures and occasionally invests in ADRs and private equity opportunities. | Finance |
Furman Selz LLC
Furman Selz LLC Investment Banks/BrokersFinance Provides institutional brokerage and investment banking services | Finance |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UBS Investment Bank (US)
UBS Investment Bank (US) Investment Banks/BrokersFinance Provides investment banking services | Finance |
Surveyor Capital Ltd.
 Surveyor Capital Ltd. Investment Trusts/Mutual FundsMiscellaneous Surveyor Capital is a global, multi-manager equities strategy and is one of Citadel’s three fundamental equities businesses. Their sector-aligned investment teams conduct deep fundamental research, developing an independent view on the companies they cover. They are specialists in their industries and experts in their coverage, building trusted relationships with many corporate management teams. The firm's investment teams leverage Citadel’s proprietary, market-neutral risk framework with the aim of building portfolios that minimize broad market exposures. Using this insight, they act on their investment theses and scale their risk-taking with confidence. | Miscellaneous |
Iguana Healthcare Management LLC
 Iguana Healthcare Management LLC Investment ManagersFinance Iguana Healthcare Management Healthcare’s investment objective is for its clients to maximum returns from investing long and short globally in public companies in the life sciences industry while actively managing both sector and global risk with an eye on capital preservation. The broad base of investment opportunities includes, but is not limited to companies focusing on biotechnology, branded pharmaceuticals, generic pharmaceutics, medical devices and medical supplies, healthcare service providers, and healthcare information technology. Iguana Healthcare clients’ portfolios are constructed using a multi-factorial approach with a focus on balancing risk and liquidity with expected returns on individual stocks and with their impact on upon overall portfolio concentration. Portfolios are constructed stock-by-stock and not sub-sector by sub-sector. | Finance |
Turret Capital Management, LP
Turret Capital Management, LP Investment ManagersFinance Turret Capital invests in companies located in the United States. The firm targets companies operating in the field of healthcare technology sector. It participates in early stage capital transactions. | Finance |
Milu Labs Ltd.
Milu Labs Ltd. Medical/Nursing ServicesHealth Services Operates as a medical diagnostics company | Health Services |
Columbia University Vagelos College of Physicians & Surgeons
 Columbia University Vagelos College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Egret Therapeutics, Inc.
Egret Therapeutics, Inc. BiotechnologyHealth Technology Develops immune therapeutics for patients with neurological diseases | Health Technology |
